Rifampin 300 MG capsule 60S
Ended Awarded
- Contract number
- SPE2DB25FRR27
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,721
Award facts
- Contract value 100% obligated
- $1,720.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 28, 2025, for the supply of Rifampin 300 mg capsules (60-count units) at a ceiling value of $1,720.96. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for ultimate completion by July 29, 2025. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 potential value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
The Defense Logistics Agency's Medical Supply Chain relies on AmerisourceBergen as a critical vendor to deliver pharmaceuticals and medical supplies supporting military and veteran healthcare systems. Rifampin is an antibiotic commonly used in the treatment of tuberculosis and other mycobacterial infections, making this procurement representative of the antimicrobial therapies essential to federal medical operations. AmerisourceBergen's demonstrated capability to fulfill federal procurement requirements through open competition, combined with its extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains, positions the company as a key supplier within DLA's pharmaceutical distribution network.
Quick answers
Who was awarded contract SPE2DB25FRR27?
SPE2DB25FRR27 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FRR27 worth?
The government has obligated $1,721 on SPE2DB25FRR27.
Is contract SPE2DB25FRR27 an order under another contract?
Yes. SPE2DB25FRR27 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRR27 competed?
The extent of competition for SPE2DB25FRR27 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award